Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112162 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiaorui Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 2…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Idiopathic Pulmonary Fibrosis, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Epidemiological evidence has indicated the occurrence of idiopathic pulmonary fibrosis (IPF) with coexisting lung cancer is not a coincidence. The pathogenic mechanisms shared between IPF and non-small cell lung cancer (NSCLC) at the transcriptional level remain elusive and need to be further elucidated. METHODS: IPF and NSCLC datasets of expression profiles were obtained from the GEO database. Firstly, to detect the shared dysregulated genes positively correlated with both IPF and NSCLC, differentially expressed analysis and WGCNA analysis were carried out. Functional enrichment and the construction of protein-protein network were employed to reveal pathogenic mechanisms related to two diseases mediated by the shared dysregulated genes. Then, the LASSO regression was adopted for screening critical candidate biomarkers for two disorders. Moreover, ROC curves were applied to evaluate the diagnostic value of the candidate biomarkers in both IPF and NSCLC. RESULTS: The 20 shared dysregulated genes positively correlated with both IPF and NSCLC were identified after intersecting differentially expressed analysis and WGCNA analysis. Functional enrichment revealed the 20 shared genes mostly enriched in extracellular region, which is critical in the organization of extracellular matrix. The protein-protein networks unrevealed the interaction of the 11 shared genes involving in collagen deposition and the connection between PYCR1 with PSAT1. PSAT1, PYCR1, COL10A1 and KIAA1683 were screened by the LASSO regression. ROC curves comprising area under the curve (AUC) verified the potential diagnostic value of PSAT1 and COL10A1 in both IPF and NSCLC. CONCLUSIONS: We revealed dysregulated extracellular matrix through aberrant expression of the relevant genes, which provided further understanding for the common molecular mechanisms predisposing the occurrence of both IPF and NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.
- Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China. Electronic address: lzclzc0928@foxmail.com.
- Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China. Electronic address: daijinghong@nju.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ding, X., Liu, H., Xu, Q., Ji, T., Chen, R., Liu, Z., & Dai, J. (2024). Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112162
Vancouver
Ding X, Liu H, Xu Q, Ji T, Chen R, Liu Z, et al. Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112162
BibTeX
@article{Ding2024,
author = {Ding, Xiaorui and Liu, Huarui and Xu, Qinghua and Ji, Tong and Chen, Ranxun and Liu, Zhengcheng and Dai, Jinghong},
title = {Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112162}
}
EUVIMED